» Articles » PMID: 22937299

Feminizing Adrenal Carcinoma Presenting with Heart Failure and Ventricular Tachycardia

Overview
Publisher Wiley
Specialty Endocrinology
Date 2012 Sep 1
PMID 22937299
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We present a case of feminizing adrenal carcinoma with severe elevation in serum estradiol and otherwise unexplained congestive heart failure with ventricular arrhythmia and review the literature on feminizing adrenal tumors and the potential relationship between estrogen and cardiac problems. A 54-year-old man presented with congestive heart failure and ventricular arrhythmia. Imaging revealed a large adrenal mass. Hormonal evaluation revealed a very high serum level of estradiol, elevated DHEA-sulfate and androstenedione, and lack of cortisol suppression on a low-dose overnight dexamethasone suppression test. The patient underwent a left adrenalectomy with subsequent normalization of serum estradiol. Surgical pathology examination established adrenocortical carcinoma MacFarlane stage II. Upon 15-month followup, the patient continued to have a normal serum estradiol level, his cardiac function was significantly improved, and he had no further episodes of ventricular arrhythmia. To the best of our knowledge, the serum estradiol level that was detected in our case is the highest that has been reported. Further, we hypothesize that the very high serum concentration of estradiol in our case may have played a role in his cardiac presentation with congestive heart failure and arrhythmia, particularly as these problems resolved with normalization of his serum estradiol level.

Citing Articles

Feminizing Adrenocortical Tumors as a Rare Etiology of Isosexual/Contrasexual Pseudopuberty.

Vuralli D, Gonc N, Ozon A, Ekinci S, Dogan H, Tekgul S J Clin Res Pediatr Endocrinol. 2021; 14(1):17-28.

PMID: 34380293 PMC: 8900075. DOI: 10.4274/jcrpe.galenos.2021.2021.0170.


Giant androgen-producing adrenocortical carcinoma with atrial flutter: A case report and review of the literature.

Costache M, Arhirii R, Mogos S, Lupascu-Ursulescu C, Litcanu C, Ciumanghel A World J Clin Cases. 2021; 9(20):5575-5587.

PMID: 34307612 PMC: 8281402. DOI: 10.12998/wjcc.v9.i20.5575.


Feminizing adrenocortical tumors: Literature review.

Chentli F, Bekkaye I, Azzoug S Indian J Endocrinol Metab. 2015; 19(3):332-9.

PMID: 25932386 PMC: 4366769. DOI: 10.4103/2230-8210.152764.

References
1.
Yang P, Kurokawa J, Furukawa T, Clancy C . Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study. PLoS Comput Biol. 2010; 6(1):e1000658. PMC: 2813260. DOI: 10.1371/journal.pcbi.1000658. View

2.
Jankowska E, Rozentryt P, Ponikowska B, Hartmann O, Kustrzycka-Kratochwil D, Reczuch K . Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009; 301(18):1892-901. DOI: 10.1001/jama.2009.639. View

3.
Zhan E, Keimig T, Xu J, Peterson E, Ding J, Wang F . Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction. Exp Physiol. 2008; 93(8):982-93. PMC: 2708104. DOI: 10.1113/expphysiol.2008.042788. View

4.
Chen Y, Lee S, Hsieh M, Hsiao C, Yu W, Chiou C . Effects of 17beta-estradiol on tachycardia-induced changes of atrial refractoriness and cisapride-induced ventricular arrhythmia. J Cardiovasc Electrophysiol. 1999; 10(4):587-98. DOI: 10.1111/j.1540-8167.1999.tb00716.x. View

5.
Kennedy B, NATHANSON I . Effects of intensive sex steroid hormone therapy in advanced breast cancer. J Am Med Assoc. 1953; 152(12):1135-41. DOI: 10.1001/jama.1953.63690120004013. View